Variant report

Variant	nsv1012567
Chromosome Location	chr2:211087588-211315554
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1142)
CpG islands
(count:1405)
Chromatin interactive
region (count:19)
LncRNA
region (count:11)
Mature miRNA
region (count: 0)
miRNA target
sites (count:1)

(count:1142 , 50 per page) page: 1 2 3 4 5 6 7 ... 23

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:211309814-211310221	K562	blood:	n/a	n/a
2	ARID3A	chr2:211309842-211310183	HepG2	liver:	n/a	n/a
3	ARID3A	chr2:211264262-211264467	HepG2	liver:	n/a	n/a
4	ARID3A	chr2:211113387-211113738	HepG2	liver:	n/a	chr2:211113389-211113405 chr2:211113390-211113406
5	BACH1	chr2:211294500-211294839	H1-hESC	embryonic stem cell:	n/a	n/a
6	BACH1	chr2:211294520-211294849	K562	blood:	n/a	n/a
7	BACH1	chr2:211286783-211287060	H1-hESC	embryonic stem cell:	n/a	n/a
8	BACH1	chr2:211089846-211090345	H1-hESC	embryonic stem cell:	n/a	n/a
9	BACH1	chr2:211089442-211089626	H1-hESC	embryonic stem cell:	n/a	n/a
10	BHLHE40	chr2:211117672-211117742	GM12878	blood:	n/a	n/a
11	BHLHE40	chr2:211307388-211307439	GM12878	blood:	n/a	n/a
12	BRCA1	chr2:211228548-211228557	HepG2	liver:	n/a	n/a
13	CBX3	chr2:211292036-211292373	K562	blood:	n/a	n/a
14	CEBPB	chr2:211126127-211126519	MCF-7	breast:	n/a	n/a
15	CEBPB	chr2:211177490-211177820	HepG2	liver:	n/a	chr2:211177640-211177649 chr2:211177640-211177651 chr2:211177638-211177649 chr2:211177638-211177651
16	CEBPB	chr2:211094725-211095046	Hela-S3	cervix:	n/a	n/a
17	CEBPB	chr2:211123634-211123928	A549	lung:	n/a	chr2:211123742-211123753
18	CEBPB	chr2:211177522-211177741	IMR90	lung:	n/a	chr2:211177640-211177649 chr2:211177640-211177651 chr2:211177638-211177649 chr2:211177638-211177651
19	CEBPB	chr2:211178099-211178158	Hela-S3	cervix:	n/a	chr2:211178132-211178141 chr2:211178130-211178141
20	CEBPB	chr2:211092133-211092295	A549	lung:	n/a	n/a
21	CEBPB	chr2:211153833-211154120	HepG2	liver:	n/a	n/a
22	CEBPB	chr2:211090100-211090474	H1-hESC	embryonic stem cell:	n/a	n/a
23	CEBPB	chr2:211090942-211091595	Hela-S3	cervix:	n/a	n/a
24	CEBPB	chr2:211126182-211126488	HepG2	liver:	n/a	n/a
25	CEBPB	chr2:211293130-211293810	Hela-S3	cervix:	n/a	chr2:211293429-211293440 chr2:211293429-211293440 chr2:211293662-211293675
26	CEBPB	chr2:211091957-211092751	Hela-S3	cervix:	n/a	chr2:211092606-211092617
27	CEBPB	chr2:211123613-211123956	HepG2	liver:	n/a	chr2:211123742-211123753
28	CEBPB	chr2:211092536-211092704	H1-hESC	embryonic stem cell:	n/a	chr2:211092606-211092617
29	CEBPB	chr2:211123715-211123833	H1-hESC	embryonic stem cell:	n/a	chr2:211123742-211123753
30	CEBPB	chr2:211293146-211293441	IMR90	lung:	n/a	chr2:211293429-211293440 chr2:211293429-211293440
31	CEBPB	chr2:211087782-211088167	Hela-S3	cervix:	n/a	chr2:211087990-211088003 chr2:211087962-211087973
32	CEBPB	chr2:211092491-211092679	HepG2	liver:	n/a	chr2:211092606-211092617
33	CEBPB	chr2:211095414-211095499	Hela-S3	cervix:	n/a	n/a
34	CEBPB	chr2:211153819-211154128	IMR90	lung:	n/a	n/a
35	CEBPB	chr2:211178085-211178214	A549	lung:	n/a	chr2:211178132-211178141 chr2:211178130-211178141
36	CEBPB	chr2:211092484-211092716	HepG2	liver:	n/a	chr2:211092606-211092617
37	CEBPB	chr2:211153891-211154063	H1-hESC	embryonic stem cell:	n/a	n/a
38	CEBPB	chr2:211087863-211088099	HepG2	liver:	n/a	chr2:211087990-211088003 chr2:211087962-211087973
39	CEBPB	chr2:211092044-211092759	HepG2	liver:	n/a	chr2:211092606-211092617
40	CEBPB	chr2:211095822-211096042	HepG2	liver:	n/a	chr2:211095949-211095962 chr2:211095951-211095962 chr2:211095951-211095962 chr2:211095949-211095960
41	CEBPD	chr2:211092485-211092734	HepG2	liver:	n/a	n/a
42	CHD1	chr2:211089543-211090182	H1-hESC	embryonic stem cell:	n/a	n/a
43	CHD2	chr2:211089927-211090159	HepG2	liver:	n/a	n/a
44	CREB1	chr2:211089454-211090096	A549	lung:	n/a	n/a
45	CTBP2	chr2:211089443-211090226	H1-hESC	embryonic stem cell:	n/a	n/a
46	CTCF	chr2:211113460-211113610	AG09319	gingival:	n/a	chr2:211113555-211113573 chr2:211113557-211113578 chr2:211113556-211113572
47	CTCF	chr2:211113500-211113650	HCM	heart:	n/a	chr2:211113555-211113573 chr2:211113557-211113578 chr2:211113556-211113572
48	CTCF	chr2:211264200-211264350	HepG2	liver:	n/a	n/a
49	CTCF	chr2:211264240-211264390	GM12801	blood:	n/a	chr2:211264345-211264363 chr2:211264340-211264361
50	CTCF	chr2:211228000-211228150	HAc	cerebellar:	n/a	n/a

(count:1405 , 50 per page) page: 1 2 3 4 5 6 7 ... 29

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:211090487-211090537	ECC-1	luminal epithelium:	n/a
2	chr2:211090271-211090321	HRPEpiC	eye:	n/a
3	chr2:211090487-211090537	ECC-1	luminal epithelium:	n/a
4	chr2:211090271-211090321	HRPEpiC	eye:	n/a
5	chr2:211090171-211090221	GM06990	blood:	n/a
6	chr2:211155085-211155135	AG10803	skin:	n/a
7	chr2:211168547-211168597	HRE	kidney:	n/a
8	chr2:211093895-211093945	Caco-2	colon:	n/a
9	chr2:211168547-211168597	HEK293	kidney:	embryo
10	chr2:211090349-211090399	GM12891	blood:	n/a
11	chr2:211090487-211090537	NH-A	brain:	n/a
12	chr2:211091510-211091560	GM19239	blood:	n/a
13	chr2:211090247-211090297	PFSK-1	brain:	n/a
14	chr2:211179902-211179952	GM12878	blood:	n/a
15	chr2:211169638-211169688	GM12878	blood:	n/a
16	chr2:211090247-211090297	HepG2	liver:	n/a
17	chr2:211090349-211090399	Caco-2	colon:	n/a
18	chr2:211096859-211096909	MCF10A-Er-Src	breast:	n/a
19	chr2:211096347-211096397	HUVEC	blood vessel:	n/a
20	chr2:211169638-211169688	SK-N-SH_RA	brain:	n/a
21	chr2:211091510-211091560	HCM	heart:	n/a
22	chr2:211179959-211180009	NT2-D1	testis:	n/a
23	chr2:211155085-211155135	MCF10A-Er-Src	breast:	n/a
24	chr2:211089678-211089728	GM19239	blood:	n/a
25	chr2:211168547-211168597	AG10803	skin:	n/a
26	chr2:211179902-211179952	AG04450	lung:	fetal
27	chr2:211179707-211179757	HRCEpiC	kidney:	n/a
28	chr2:211090349-211090399	HAEpiC	amniotic membrane:	n/a
29	chr2:211169638-211169688	LNCaP	prostate:	n/a
30	chr2:211179902-211179952	AG04449	skin:	fetal
31	chr2:211090323-211090373	HRE	kidney:	n/a
32	chr2:211090171-211090221	PrEC	prostate:	n/a
33	chr2:211089678-211089728	GM12891	blood:	n/a
34	chr2:211180386-211180436	PANC-1	pancreas:	n/a
35	chr2:211155085-211155135	NHBE	bronchial:	n/a
36	chr2:211093895-211093945	GM12878	blood:	n/a
37	chr2:211179560-211179610	Hela-S3	cervix:	n/a
38	chr2:211169638-211169688	PANC-1	pancreas:	n/a
39	chr2:211179959-211180009	HepG2	liver:	n/a
40	chr2:211180001-211180051	SK-N-SH	brain:	n/a
41	chr2:211179959-211180009	PANC-1	pancreas:	n/a
42	chr2:211179707-211179757	HCPEpiC	choroid plexus:	n/a
43	chr2:211096347-211096397	NT2-D1	testis:	n/a
44	chr2:211155085-211155135	HRE	kidney:	n/a
45	chr2:211179902-211179952	NB4	blood:	n/a
46	chr2:211090281-211090331	HRE	kidney:	n/a
47	chr2:211179707-211179757	AG10803	skin:	n/a
48	chr2:211096347-211096397	NB4	blood:	n/a
49	chr2:211179959-211180009	HRCEpiC	kidney:	n/a
50	chr2:211168547-211168597	GM12891	blood:	n/a

(count:19 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr2:211227904..211228774-chr2:211263806..211264757,2	MCF-7	breast:
2	chr17:41464702..41466633-chr2:211088015..211091015,4	MCF-7	breast:
3	chr17:41465713..41467651-chr2:211089515..211091035,2	K562	blood:
4	chr2:211128325..211129018-chr2:211137774..211138284,2	MCF-7	breast:
5	chr2:211113028..211114042-chr2:211263878..211264898,6	MCF-7	breast:
6	chr2:211082052..211083888-chr2:211086942..211089346,2	K562	blood:
7	chr2:211173735..211175248-chr2:211176739..211178731,2	MCF-7	breast:
8	chr2:211106656..211109050-chr2:211112844..211114921,2	K562	blood:
9	chr2:211227904..211228774-chr2:211263806..211264757,2	MCF-7	breast:
10	chr2:211309754..211310533-chr2:211481854..211482775,2	MCF-7	breast:
11	chr2:211113028..211114042-chr2:211263878..211264898,6	MCF-7	breast:
12	chr17:41463157..41466155-chr2:211088015..211089515,2	K562	blood:
13	chr2:211112989..211113918-chr2:211900038..211900547,2	MCF-7	breast:
14	chr17:41466368..41468065-chr2:211089535..211091035,2	K562	blood:
15	chr2:211106656..211109050-chr2:211112844..211114921,2	K562	blood:
16	chr2:211173735..211175248-chr2:211176739..211178731,2	MCF-7	breast:
17	chr12:124746104..124746706-chr2:211100326..211100835,2	MCF-7	breast:
18	chr2:211128325..211129018-chr2:211137774..211138284,2	MCF-7	breast:
19	chr2:211293517..211296433-chr2:211339377..211342364,2	MCF-7	breast:

(count:11 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-RPE-9	chr2:211097416-211098700	NONHSAT076676
2	lnc-CPS1-1	chr2:211307266-211307423	ENSG00000234281.1
3	lnc-CPS1-1	chr2:211292473-211292647	ENSG00000234281.1
4	lnc-CPS1-1	chr2:211292764-211292881	ENSG00000234281.1
5	lnc-CPS1-2	chr2:211190540-211192675	ucscGeneNc_uc002vef_1
6	lnc-RPE-2	chr2:211095007-211095107	ENSG00000231294.1
7	lnc-CPS1-1	chr2:211189490-211189558	ENSG00000234281.1
8	lnc-CPS1-1	chr2:211294089-211294175	ENSG00000234281.1
9	lnc-C2orf67-2	chr2:211089039-211089573	NONHSAT076675
10	lnc-CPS1-1	chr2:211294089-211294175	ENSG00000234281.1
11	lnc-CPS1-1	chr2:211189483-211189558	ENSG00000234281.1

No data

(count:1 , 50 per page) page: 1

No.	miRNA target gene	miRNA name	Chromosome Location	mirBase accession
1	LANCL1	hsa-miR-7-5p	chr2:211299139-211299165

Variant related genes	Relation type
ACADL	TF binding region
ENSG00000199203	TF binding region
MYL1	TF binding region
ENSG00000234281	TF binding region
LANCL1	TF binding region
ACADL	CpG island
ENSG00000199203	CpG island
MYL1	CpG island
ENSG00000234281	CpG island
LANCL1	CpG island
ENSG00000188825	chromatin interactions
ENSG00000115365	chromatin interactions

Extended variants
information (count: 5294 )
Associated
traits (count: 59 )

Variant overlapped rSNPs/rCNVs (count:5294 , 50 per page) page: 1 2 3 4 5 6 7 ... 106

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs555874783	chr2:211087589-211087590	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs147197980	chr2:211087592-211087593	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs371488241	chr2:211087607-211087608	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs139925225	chr2:211087721-211087722	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs572937024	chr2:211087744-211087745	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs145457784	chr2:211087880-211087881	Weak transcription Enhancers Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs373169460	chr2:211087980-211087981	Weak transcription Enhancers Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs546012847	chr2:211088021-211088022	Weak transcription Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs550447005	chr2:211088105-211088106	Weak transcription Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs374023981	chr2:211088117-211088118	Weak transcription Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs572263015	chr2:211088129-211088130	Weak transcription Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs534613686	chr2:211088146-211088147	Weak transcription Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs557926731	chr2:211088147-211088148	Weak transcription Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs577949078	chr2:211088158-211088159	Weak transcription Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs113399842	chr2:211088220-211088221	Weak transcription Enhancers Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs367678612	chr2:211088242-211088243	Weak transcription Enhancers Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs546300785	chr2:211088258-211088259	Weak transcription Enhancers Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs555141374	chr2:211088275-211088276	Weak transcription Enhancers Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs147703754	chr2:211088298-211088299	Weak transcription Enhancers Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs568834415	chr2:211088370-211088371	Weak transcription Enhancers Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs73984351	chr2:211088371-211088372	Weak transcription Enhancers Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs140934215	chr2:211088381-211088382	Weak transcription Enhancers Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs527984943	chr2:211088409-211088410	Weak transcription Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs567924191	chr2:211088438-211088439	Weak transcription Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs547816749	chr2:211088472-211088473	Weak transcription Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs535359225	chr2:211088487-211088488	Weak transcription Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs149779245	chr2:211088508-211088509	Weak transcription Enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs575191786	chr2:211088615-211088616	Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
29	rs188869257	chr2:211088616-211088617	Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs145858248	chr2:211088677-211088678	Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs569375834	chr2:211088743-211088744	Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
32	rs535183970	chr2:211088762-211088763	Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
33	rs74744721	chr2:211088780-211088781	Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
34	rs565583536	chr2:211088800-211088801	Bivalent/Poised TSS Weak transcription Flanking Active TSS Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
35	rs116035489	chr2:211088806-211088807	Bivalent/Poised TSS Weak transcription Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
36	rs1848709	chr2:211088816-211088817	Bivalent/Poised TSS Weak transcription Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
37	rs77140618	chr2:211088819-211088820	Bivalent/Poised TSS Weak transcription Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
38	rs376668980	chr2:211088837-211088838	Bivalent/Poised TSS Weak transcription Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
39	rs181251669	chr2:211088871-211088872	Bivalent/Poised TSS Weak transcription Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
40	rs71350736	chr2:211088888-211088889	Bivalent/Poised TSS Weak transcription Active TSS Enhancers	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs542005772	chr2:211088920-211088921	Bivalent/Poised TSS Weak transcription Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
42	rs562105132	chr2:211088924-211088925	Bivalent/Poised TSS Weak transcription Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
43	rs2539006	chr2:211088946-211088947	Bivalent/Poised TSS Weak transcription Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs34460820	chr2:211088949-211088950	Bivalent/Poised TSS Weak transcription Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs71043982	chr2:211088963-211088964	Bivalent/Poised TSS Weak transcription Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs542689448	chr2:211088981-211088982	Bivalent/Poised TSS Weak transcription Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs572382448	chr2:211088993-211088994	Bivalent/Poised TSS Weak transcription Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs185361015	chr2:211088996-211088997	Bivalent/Poised TSS Weak transcription Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs564410599	chr2:211089016-211089017	Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs533461220	chr2:211089022-211089023	Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:59)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Ependymoma	16718352	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	17603634	CNVD
Testicular germ cell tumor	18059402	CNVD
Breast cancer	16272173	CNVD
Ewing''s sarcoma	17952124	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
Colorectal cancer	16272173	CNVD
Lung cancer	18438408	CNVD
Prostate cancer	18632612	CNVD
Acute myeloid leukemia	20729466	CNVD
small cell lung cancer	20016488	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Urothelial carcinoma	21177765	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cervical cancer	21062161	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Non-muscle invasive bladder neoplasm	19445696	CNVD
Non-small cell lung cancer	21829676	CNVD
Autism	20808228	CNVD
Renal cell carcinoma	18765545	CNVD
Ovarian cancer	19193619	CNVD
Non-small cell lung cancer	18676828	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Chordoma	18071362	CNVD
Myelofibrosis	22110671	CNVD
Schizophrenia	18923514	CNVD
Schizophrenia	22241247	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Urothelial cell carcinoma	18451213	CNVD
Developmental delay	21147756	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:1376 , 50 per page) page: 1 2 3 4 5 6 7 ... 28

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:211060400-211089000	Weak transcription	Skeletal Muscle Female	skeletal muscle
2	chr2:211067800-211089200	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
3	chr2:211080200-211089400	Weak transcription	Gastric	stomach
4	chr2:211086600-211087600	Enhancers	Pancreas	Pancrea
5	chr2:211086600-211088200	Enhancers	Liver	Liver
6	chr2:211086600-211088400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
7	chr2:211086600-211088600	Enhancers	Adipose Nuclei	Adipose
8	chr2:211086800-211087600	Enhancers	Placenta	Placenta
9	chr2:211086800-211087800	Enhancers	Hela-S3	cervix
10	chr2:211087400-211087600	Flanking Active TSS	Aorta	Aorta
11	chr2:211087400-211087600	Bivalent Enhancer	HepG2	liver
12	chr2:211087600-211088600	Weak transcription	Pancreas	Pancrea
13	chr2:211087600-211091000	Active TSS	Aorta	Aorta
14	chr2:211087800-211088000	Bivalent Enhancer	Fetal Lung	lung
15	chr2:211087800-211090200	Weak transcription	Hela-S3	cervix
16	chr2:211088200-211088400	Flanking Active TSS	Liver	Liver
17	chr2:211088400-211088600	Enhancers	Liver	Liver
18	chr2:211088400-211089200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
19	chr2:211088600-211088800	Flanking Active TSS	Adipose Nuclei	Adipose
20	chr2:211088600-211088800	Flanking Active TSS	Liver	Liver
21	chr2:211088600-211090600	Active TSS	Pancreas	Pancrea
22	chr2:211088800-211089000	Enhancers	Liver	Liver
23	chr2:211088800-211089400	Active TSS	Adipose Nuclei	Adipose
24	chr2:211088800-211090600	Bivalent/Poised TSS	ES-WA7 Cell Line	embryonic stem cell
25	chr2:211089000-211089200	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
26	chr2:211089000-211089200	Enhancers	Cortex derived primary cultured neurospheres	brain
27	chr2:211089000-211089200	Bivalent Enhancer	Fetal Intestine Large	intestine
28	chr2:211089000-211089400	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
29	chr2:211089000-211089400	Active TSS	Rectal Smooth Muscle	rectum
30	chr2:211089000-211089600	Flanking Active TSS	Liver	Liver
31	chr2:211089000-211089600	Active TSS	Brain Inferior Temporal Lobe	brain
32	chr2:211089000-211090000	Active TSS	Skeletal Muscle Male	skeletal muscle
33	chr2:211089000-211090000	Active TSS	Skeletal Muscle Female	skeletal muscle
34	chr2:211089000-211090200	Active TSS	Brain Anterior Caudate	brain
35	chr2:211089000-211090600	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
36	chr2:211089000-211090600	Active TSS	Pancreatic Islets	Pancreatic Islet
37	chr2:211089000-211090600	Active TSS	Right Atrium	heart
38	chr2:211089000-211091000	Bivalent/Poised TSS	Fetal Kidney	kidney
39	chr2:211089200-211089400	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
40	chr2:211089200-211089400	Bivalent Enhancer	Primary hematopoietic stem cells short term culture	blood
41	chr2:211089200-211089400	Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
42	chr2:211089200-211089400	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
43	chr2:211089200-211089400	Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
44	chr2:211089200-211089400	Bivalent/Poised TSS	Duodenum Mucosa	Duodenum
45	chr2:211089200-211089400	Bivalent/Poised TSS	Fetal Brain Male	brain
46	chr2:211089200-211089400	Active TSS	Fetal Brain Female	brain
47	chr2:211089200-211089400	Bivalent/Poised TSS	Fetal Muscle Trunk	muscle
48	chr2:211089200-211089400	Bivalent Enhancer	Stomach Mucosa	stomach
49	chr2:211089200-211089400	Flanking Bivalent TSS/Enh	HepG2	liver
50	chr2:211089200-211089400	Bivalent/Poised TSS	HUVEC	blood vessel

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links